Why pharmacists should manage repeat prescriptions
Professor Ashok Soni OBE is a community pharmacist and president of the National Association of Primary Care. He recently called on the Government to make better use of […]
Professor Ashok Soni OBE is a community pharmacist and president of the National Association of Primary Care. He recently called on the Government to make better use of […]
Rob Horne, Professor of Behavioural Medicine at University College London School of Pharmacy, leads a research group focused on the psychology of medicines and understanding patient perspectives of […]
Some additional training may be required to enable community pharmacists to use behavioural approaches to improve outcomes for patients and a computerised triage tool could help to make […]
The proportion of opioid overdose deaths involving buprenorphine, a medication used to treat opioid use disorder, did not increase in the months after prescribing flexibilities were put in […]
Rob Horne, Professor of Behavioural Medicine at University College London School of Pharmacy, has no doubt that evidence supports the use of psychological and behavioural techniques to improve […]
Rob Horne, Professor of Behavioural Medicine at University College London School of Pharmacy, leads a research group focused on the psychology of medicines and understanding patient perspectives of […]
New research from Boston Medical Center found that enhancing pharmacy services for patients with high levels of health care utilization did not lead to reduced hospital admissions and […]
David Wright, Professor of Health Services Research at the University of Leicester leads a research team focused on design and implementation of routine pharmacogenomics (PGx) services in community […]
A growing number of studies are now providing evidence for the benefits of pharmacogenomics testing (PGx) services. What is now needed is a study to demonstrate the effectiveness […]
New research reveals private equity firms that acquire physician-owned medical practices experience greater replacement of the workforce and rely more heavily on advanced practice providers — such as […]
Actionable drug-genome interactions (DGIs) are found in one in five tests and this makes the processes of obtaining informed consent for testing and follow-up of test results particularly […]
The process of designing a pharmacogenomic testing service for Community Pharmacy was described in a poster presented at the 80th FIP World Congress in Seville. David Wright, Professor […]